265 related articles for article (PubMed ID: 35563596)
21. Glycation in Parkinson's disease and Alzheimer's disease.
Vicente Miranda H; El-Agnaf OM; Outeiro TF
Mov Disord; 2016 Jun; 31(6):782-90. PubMed ID: 26946341
[TBL] [Abstract][Full Text] [Related]
22. Acetylation as a major determinant to microtubule-dependent autophagy: Relevance to Alzheimer's and Parkinson disease pathology.
Esteves AR; Palma AM; Gomes R; Santos D; Silva DF; Cardoso SM
Biochim Biophys Acta Mol Basis Dis; 2019 Aug; 1865(8):2008-2023. PubMed ID: 30572013
[TBL] [Abstract][Full Text] [Related]
23. Broad neutralization of calcium-permeable amyloid pore channels with a chimeric Alzheimer/Parkinson peptide targeting brain gangliosides.
Di Scala C; Yahi N; Flores A; Boutemeur S; Kourdougli N; Chahinian H; Fantini J
Biochim Biophys Acta; 2016 Feb; 1862(2):213-22. PubMed ID: 26655601
[TBL] [Abstract][Full Text] [Related]
24. Biophysical studies of protein misfolding and aggregation in
Sinnige T; Stroobants K; Dobson CM; Vendruscolo M
Q Rev Biophys; 2020 Jun; 49():e22. PubMed ID: 32493529
[TBL] [Abstract][Full Text] [Related]
25. Faster disease progression in Parkinson's disease with type 2 diabetes is not associated with increased α-synuclein, tau, amyloid-β or vascular pathology.
de Pablo-Fernández E; Courtney R; Rockliffe A; Gentleman S; Holton JL; Warner TT
Neuropathol Appl Neurobiol; 2021 Dec; 47(7):1080-1091. PubMed ID: 33969516
[TBL] [Abstract][Full Text] [Related]
26. Neuropathological and Biomarker Findings in Parkinson's Disease and Alzheimer's Disease: From Protein Aggregates to Synaptic Dysfunction.
Compta Y; Revesz T
J Parkinsons Dis; 2021; 11(1):107-121. PubMed ID: 33325398
[TBL] [Abstract][Full Text] [Related]
27. Formation of hydrogen peroxide and hydroxyl radicals from A(beta) and alpha-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease.
Tabner BJ; Turnbull S; El-Agnaf OM; Allsop D
Free Radic Biol Med; 2002 Jun; 32(11):1076-83. PubMed ID: 12031892
[TBL] [Abstract][Full Text] [Related]
28. Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia.
Vallortigara J; Whitfield D; Quelch W; Alghamdi A; Howlett D; Hortobágyi T; Johnson M; Attems J; O'Brien JT; Thomas A; Ballard CG; Aarsland D; Francis PT
J Alzheimers Dis; 2016; 50(1):101-10. PubMed ID: 26639969
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases.
Tsigelny IF; Crews L; Desplats P; Shaked GM; Sharikov Y; Mizuno H; Spencer B; Rockenstein E; Trejo M; Platoshyn O; Yuan JX; Masliah E
PLoS One; 2008 Sep; 3(9):e3135. PubMed ID: 18769546
[TBL] [Abstract][Full Text] [Related]
30. Aβ, Tau, and α-Synuclein aggregation and integrated role of PARK2 in the regulation and clearance of toxic peptides.
Kumar D; Kumar P
Neuropeptides; 2019 Dec; 78():101971. PubMed ID: 31540705
[TBL] [Abstract][Full Text] [Related]
31. Production of reactive oxygen species from aggregating proteins implicated in Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases.
Tabner BJ; Turnbull S; El-Agnaf O; Allsop D
Curr Top Med Chem; 2001 Dec; 1(6):507-17. PubMed ID: 11895127
[TBL] [Abstract][Full Text] [Related]
32. Changes in Expression Profiles Revealed by Transcriptomic Analysis in Peripheral Blood Mononuclear Cells of Alzheimer's Disease Patients.
Leandro GS; Evangelista AF; Lobo RR; Xavier DJ; Moriguti JC; Sakamoto-Hojo ET
J Alzheimers Dis; 2018; 66(4):1483-1495. PubMed ID: 30400085
[TBL] [Abstract][Full Text] [Related]
33. Role of Alcohol Drinking in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.
Peng B; Yang Q; B Joshi R; Liu Y; Akbar M; Song BJ; Zhou S; Wang X
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230811
[TBL] [Abstract][Full Text] [Related]
34. Associations Between APOE Variants, Tau and α-Synuclein.
Rodriguez-Vieitez E; Nielsen HM
Adv Exp Med Biol; 2019; 1184():177-186. PubMed ID: 32096038
[TBL] [Abstract][Full Text] [Related]
35. Oligomeric α-Syn and SNARE complex proteins in peripheral extracellular vesicles of neural origin are biomarkers for Parkinson's disease.
Agliardi C; Meloni M; Guerini FR; Zanzottera M; Bolognesi E; Baglio F; Clerici M
Neurobiol Dis; 2021 Jan; 148():105185. PubMed ID: 33217562
[TBL] [Abstract][Full Text] [Related]
36. Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: Examples of amyloidopathies, tauopathies and synucleinopathies.
Bourdenx M; Koulakiotis NS; Sanoudou D; Bezard E; Dehay B; Tsarbopoulos A
Prog Neurobiol; 2017 Aug; 155():171-193. PubMed ID: 26209472
[TBL] [Abstract][Full Text] [Related]
37. Alzheimer's, Parkinson's Disease and Amyotrophic Lateral Sclerosis Gene Expression Patterns Divergence Reveals Different Grade of RNA Metabolism Involvement.
Garofalo M; Pandini C; Bordoni M; Pansarasa O; Rey F; Costa A; Minafra B; Diamanti L; Zucca S; Carelli S; Cereda C; Gagliardi S
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33327559
[TBL] [Abstract][Full Text] [Related]
38. Neuronal response in Alzheimer's and Parkinson's disease: the effect of toxic proteins on intracellular pathways.
Majd S; Power JH; Grantham HJ
BMC Neurosci; 2015 Oct; 16():69. PubMed ID: 26499115
[TBL] [Abstract][Full Text] [Related]
39. Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores.
Bayer TA; Jäkälä P; Hartmann T; Havas L; McLean C; Culvenor JG; Li QX; Masters CL; Falkai P; Beyreuther K
Neurosci Lett; 1999 May; 266(3):213-6. PubMed ID: 10465711
[TBL] [Abstract][Full Text] [Related]
40. Involvement of alpha-synuclein in Parkinson's disease and other neurodegenerative disorders.
Krüger R; Müller T; Riess O
J Neural Transm (Vienna); 2000; 107(1):31-40. PubMed ID: 10809401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
